The landscape of copy number variations in Finnish families with autism spectrum disorders

• Published in: Autism research 2016-01, Vol.9 (1), p.9-16
• Main Authors: Kanduri, Chakravarthi, Kantojärvi, Katri, Salo, Paula M, Vanhala, Raija, Buck, Gemma, Blancher, Christine, Lähdesmäki, Harri, Järvelä, Irma
• Format: Article
• Language: English
• Subjects: Autism Spectrum Disorder - genetics; autism spectrum disorders; Case-Control Studies; copy number variations; DNA Copy Number Variations - genetics; Finland; Finnish population; Genetic Predisposition to Disease - genetics; genome wide SNP arrays; Humans; Polymorphism, Single Nucleotide - genetics; Risk Factors
• ISSN: 1939-3792; 1939-3806
• DOI: 10.1002/aur.1502

Rare de novo and inherited copy number variations (CNVs) have been implicated in autism spectrum disorder (ASD) risk. However, the genetic underpinnings of ASD remain unknown in more than 80% of cases. Therefore, identification of novel candidate genes and corroboration of known candidate genes may broaden the horizons of determining genetic risk alleles, and subsequent development of diagnostic testing. Here, using genotyping arrays, we characterized the genetic architecture of rare CNVs (1 Mb) CNVs and rare, exonic CNVs. The exonic rare de novo CNV rate (∼22.5%) seemed higher compared to previous reports. We identified several CNVs in well‐known ASD regions including GSTM1‐5, DISC1, FHIT, RBFOX1, CHRNA7, 15q11.2, 15q13.2‐q13.3, 17q12, and 22q11.21. Additionally, several novel candidate genes (BDKRB1, BDKRB2, AP2M1, SPTA1, PTH1R, CYP2E1, PLCD3, F2RL1, UQCRC2, LILRB3, RPS9, and COL11A2) were identified through gene prioritization. The majority of these genes belong to neuroactive ligand–receptor interaction pathways, and calcium signaling pathways, thus suggesting that a subset of these novel candidate genes may contribute to ASD risk. Furthermore, several metabolic pathways like caffeine metabolism, drug metabolism, retinol metabolism, and calcium‐signaling pathway were found to be affected by the rare exonic ASD CNVs. Additionally, biological processes such as bradykinin receptor activity, endoderm formation and development, and oxidoreductase activity were enriched among the rare exonic ASD CNVs. Overall, our findings may add data about new genes and pathways that contribute to the genetic architecture of ASD. Autism Res 2015. © 2015 International Society for Autism Research, Wiley Periodicals, Inc.